■ adults and children 12 years of age and older: ■ apply a thin layer to affected area using roller ball every 6 to 8 hours, not more than 3 to 4 times daily ■ massage as needed ■ if product unintentionally gets on hands, wash hands thoroughly with soap and water after each use ■ children under 12 years of age: ask a doctor
ASPERCREME LIDOCAINE WITH LAVENDER NO-MESS
Drug Facts
Lidocaine HCl 4%
Topical anesthetic
for the temporary relief of pain
For external use only
Flammable ■ keep away from heat and open flame
■ in large quantities
■ on wounds or on irritated or damaged skin
■ with a heating pad
■ use only as directed
■ do not bandage tightly
■ avoid contact with eyes and mucous membranes
■ do not expose the area to local heat or to direct sunlight
■ condition worsens or symptoms persist for more than 7 days
■ symptoms clear up and occur again within a few days
■ redness is present or excessive skin irritation occurs
■ you experience severe burning pain, swelling, or blistering where the product was applied
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away.
■ adults and children 12 years of age and older:
■ apply a thin layer to affected area using roller ball every 6 to 8 hours, not more than 3 to 4 times daily
■ massage as needed
■ if product unintentionally gets on hands, wash hands thoroughly with soap and water after each use
■ children under 12 years of age: ask a doctor
acrylates/C10-30 alkyl acrylate crosspolymer, alcohol denat. (15%), aloe barbadensis leaf juice, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, dicetyl phosphate, dimethicone, disodium EDTA, ethylhexylglycerin, glyceryl stearate, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, isohexadecane, lavandula angustifolia (lavender) oil, methylparaben, polysorbate 60, steareth-2, steareth-21, water
Child-resistant packaging. Replace cap after each use.
MAX STRENGTH
Aspercreme
with 4% LIDOCAINE
PAIN RELIEF LIQUID
With LAVENDER Essential Oil
2.5 FL OZ (73 mL)
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41167-0568 | 41167-0568-5, 41167-0568-6 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 7 | 2026-01-13 | monthly-update | 2026-06-03 17:52:34 |
| 6 | 2023-10-25 | full-release | 2026-05-31 23:57:41 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspercreme Lidocaine No-Mess plus Lavender | LIDOCAINE HCL | Chattem, Inc. | 3948a3d2-ce04-4703-8709-211e75c9c38d | 2026-07-29 | Warnings | 41167-0568-6 41167-0568-5 41167-0568 41167056805 41167056806 6d2e62cf-00b1-4361-9aaf-a30807f198c0 3948a3d2-ce04-4703-8709-211e75c9c38d |
Adverse event summaries are temporarily unavailable. Other product information remains available.